BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16117710)

  • 21. Bat rabies surveillance in the former Soviet Union.
    Kuzmin IV; Botvinkin AD; Poleschuk EM; Orciari LA; Rupprecht CE
    Dev Biol (Basel); 2006; 125():273-82. PubMed ID: 16878485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occupational lyssavirus risks and post-vaccination monitoring.
    Brookes SM; Fooks AR
    Dev Biol (Basel); 2006; 125():165-73. PubMed ID: 16878474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidemiology of rabies virus and other lyssaviruses].
    Arai YT
    Nihon Rinsho; 2005 Dec; 63(12):2167-72. PubMed ID: 16363690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Favourable outcome in a patient bitten by a rabid bat infected with the European bat lyssavirus-1.
    Van Gucht S; Verlinde R; Colyn J; Vanderpas J; Vanhoof R; Roels S; Francart A; Brochier B; Suin V
    Acta Clin Belg; 2013; 68(1):54-8. PubMed ID: 23627196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rabies prophylaxis in Western Australia: the impact of Australian bat lyssavirus.
    Torvaldsen S; Watson T
    Commun Dis Intell; 1998 Aug; 22(8):149-52. PubMed ID: 9735544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Postexposure prophylaxis after bite of a broad-winged bat with evidence of European bat lyssavirus 1 (EBLV-1)].
    Fasse J; Trawinski H; Hardt M; Lübbert C
    Inn Med (Heidelb); 2024 Jun; 65(6):608-611. PubMed ID: 38100072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ability of rabies vaccine strains to elicit cross-neutralising antibodies.
    Brookes SM; Healy DM; Fooks AR
    Dev Biol (Basel); 2006; 125():185-93. PubMed ID: 16878476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging aspects of rabies infection: with a special emphasis on children.
    Warrell MJ
    Curr Opin Infect Dis; 2008 Jun; 21(3):251-7. PubMed ID: 18448969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and Antigenetic Characterization of the Novel Kotalahti Bat Lyssavirus (KBLV).
    Calvelage S; Tammiranta N; Nokireki T; Gadd T; Eggerbauer E; Zaeck LM; Potratz M; Wylezich C; Höper D; Müller T; Finke S; Freuling CM
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33419096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RT-PCR for detection of all seven genotypes of Lyssavirus genus.
    Vázquez-Morón S; Avellón A; Echevarría JE
    J Virol Methods; 2006 Aug; 135(2):281-7. PubMed ID: 16713633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of rabies biologics against new lyssaviruses from Eurasia.
    Hanlon CA; Kuzmin IV; Blanton JD; Weldon WC; Manangan JS; Rupprecht CE
    Virus Res; 2005 Jul; 111(1):44-54. PubMed ID: 15896401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus.
    Shipley R; Wright E; Smith SP; Selden D; Fooks AR; Banyard AC
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Viruses and bats: rabies and Lyssavirus].
    Tordo N; Marianneau MP
    Bull Mem Acad R Med Belg; 2009; 164(1-2):7-15; discussion 15-6. PubMed ID: 19718950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Pan-Lyssavirus Taqman Real-Time RT-PCR Assay for the Detection of Highly Variable Rabies virus and Other Lyssaviruses.
    Wadhwa A; Wilkins K; Gao J; Condori Condori RE; Gigante CM; Zhao H; Ma X; Ellison JA; Greenberg L; Velasco-Villa A; Orciari L; Li Y
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005258. PubMed ID: 28081126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-protective and cross-reactive immune responses to recombinant vaccinia viruses expressing full-length lyssavirus glycoprotein genes.
    Weyer J; Kuzmin IV; Rupprecht CE; Nel LH
    Epidemiol Infect; 2008 May; 136(5):670-8. PubMed ID: 17588277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-Neutralization Activities of Antibodies against 18 Lyssavirus Glycoproteins.
    Inoue Y; Kaku Y; Harada M; Ishijima K; Kuroda Y; Tatemoto K; Virhuez-Mendoza M; Nishino A; Yamamoto T; Inoue S; Matsuu A; Maeda K
    Jpn J Infect Dis; 2024 May; 77(3):169-173. PubMed ID: 38171846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WHO Expert Consultation on rabies.
    World Health Organ Tech Rep Ser; 2005; 931():1-88, back cover. PubMed ID: 16485446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective activity of a murine monoclonal antibody against European bat lyssavirus 1 (EBL1) infection in mice.
    Montaño-Hirose JA; Lafage M; Weber P; Badrane H; Tordo N; Lafon M
    Vaccine; 1993 Sep; 11(12):1259-66. PubMed ID: 8256507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition.
    Kuzmin IV; Hughes GJ; Botvinkin AD; Orciari LA; Rupprecht CE
    Virus Res; 2005 Jul; 111(1):28-43. PubMed ID: 15896400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bat rabies in Europe and the Czech Republic].
    Helesic J; Bartonícka T; Krbková L
    Klin Mikrobiol Infekc Lek; 2007 Jun; 13(3):93-8. PubMed ID: 17703400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.